Coronary Pressure Devices Market Report 2024

This Coronary Pressure Devices market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The Coronary Pressure Devices market size has grown strongly in recent years. It will grow from $15.81 billion in 2023 to $17.38 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to the increasing incidence of cardiovascular diseases, higher demand for Coronary Pressure Devices monitoring, greater awareness of heart health, and rising healthcare expenditure.

The Coronary Pressure Devices market size is expected to see rapid growth in the next few years. It will grow to $25.45 billion in 2028 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to the increasing prevalence of coronary artery disease (CAD), a growing elderly population, greater adoption of minimally invasive procedures, and heightened awareness of early disease detection. Key trends during this period include technological advancements, more cost-effective treatments, improved healthcare access, and the introduction of new products and services.

The rising prevalence of cardiovascular diseases is expected to drive growth in the Coronary Pressure Devices market. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, which are often associated with lifestyle factors and genetics. The increase in cardiovascular disease rates is attributed to factors such as unhealthy diets, sedentary lifestyles, and rising obesity levels. Coronary Pressure Devices are essential for assessing and managing these conditions by measuring coronary artery pressures, guiding treatment decisions, and improving patient outcomes. For example, a study published in August 2022 in the Journal of the American College of Cardiology projected an increase in all four cardiovascular risk factors among the U.S. population from 2025 to 2060. The study highlighted diabetes with the highest projected increase at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). Additionally, significant increases were anticipated in heart failure (33.4%) and ischemic heart disease (30.7%), with heart attack (16.9%) and stroke (33.8%) also showing notable rises. This growing prevalence of cardiovascular diseases is a key driver of the Coronary Pressure Devices market.

Leading companies in the Coronary Pressure Devices market are innovating with new products, such as advanced ambulatory blood pressure monitoring (ABPM) kits, to improve patient care and management of cardiovascular diseases. ABPM kits are non-invasive diagnostic tools designed to continuously measure blood pressure over a 24-hour period. For instance, in May 2021, Biobeat Technologies, an Israel-based medical equipment manufacturer, introduced an advanced ABPM device that operates without a traditional cuff. This chest-worn monitor enables patients to track their blood pressure, heart rate, mean arterial pressure, cardiac output, and systemic vascular resistance throughout their daily activities, offering a comprehensive view of their cardiac health. The device is designed for easy self-setup at home, eliminating the need for medical personnel during installation, and provides real-time data directly to patients' smartphones via an app, while physicians can access detailed reports through an online platform.

In May 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical technology company, acquired Shockwave Medical Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson's presence in the cardiovascular market, improve treatment options for patients, and support long-term financial growth. Shockwave Medical Inc., a US-based provider of Coronary Pressure Devices, will contribute to Johnson & Johnson's expanded portfolio in this sector.

Major companies operating in the Coronary Pressure Devices market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Philips Healthcare, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International.

North America was the largest region in the Coronary Pressure Devices market in 2023. The regions covered in the Coronary Pressure Devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Coronary Pressure Devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Coronary Pressure Devices is the pressure within the coronary arteries that deliver blood and oxygen to the heart muscle. This measure is vital for evaluating how well blood flow and oxygen are reaching the heart. Factors such as heart rate, blood volume, and arterial resistance affect Coronary Pressure Devices, making its monitoring key for diagnosing and managing coronary artery disease.

Devices used to measure Coronary Pressure Devices include sphygmomanometers, automated blood pressure monitors, blood pressure (BP) transducers, and ambulatory blood pressure monitors. A sphygmomanometer is used to manually measure blood pressure and usually features an inflatable cuff, a pressure gauge, and a bulb for inflation. These devices are available in digital, aneroid, and wearable forms and are utilized by various end users such as hospitals, cardiac care centers, ambulatory centers, homecare settings, and academic institutions.

The Coronary Pressure Devices market research report is one of a series of new reports that provides Coronary Pressure Devices market statistics, including Coronary Pressure Devices industry global market size, regional shares, competitors with a Coronary Pressure Devices market share, detailed Coronary Pressure Devices market segments, market trends and opportunities, and any further data you may need to thrive in the Coronary Pressure Devices industry. This Coronary Pressure Devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The Coronary Pressure Devices market consists of sales of fractional flow reserve (FFR) wire, instantaneous wave-free ratio (iFR) wire, pressure monitoring manifolds, and pressure measurement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.